JB Chemicals & Pharmaceuticals Limited reported an 8% revenue increase in Q2 FY26, reaching INR 1,085 crores. Domestic formulations grew by 9%, and the international business also contributed positively. The company continues to focus on key brands and strategic growth initiatives, demonstrating consistent financial performance. Strong ROCE and cash flow generation remain priorities.
Financial Highlights for Q2 FY26
JB Chemicals & Pharmaceuticals Limited announced its financial results for Q2 FY26, showcasing solid growth and consistent performance:
- Revenue increased by 8% to INR 1,085 crores, compared to INR 1,001 crores in Q2 FY25.
- Domestic formulations business grew by 9%, with revenue reaching INR 644 crores.
- International business also contributed positively, with revenue increasing by 7% to INR 441 crores.
EBITDA and Margins
The company also reported strong EBITDA and margin performance:
- Operating EBITDA grew by 12% to INR 319 crores, compared to INR 285 crores in the previous year.
- Operating EBITDA margin stood at 29.4%.
Domestic Business Performance
The domestic business maintained its growth trajectory, with several key brands performing well:
- JB Pharma outperformed the Indian Pharmaceutical Market (IPM), with a growth of 12%.
- Key brands, including Cilacar, Cilacar-T, Metrogyl, Nicardia, and Sporlac, gained market share.
- The Razel franchise achieved sales of over INR 100 crores.
International Business Update
The international business showed resilience and growth in key markets:
- CDMO business grew by 20%, contributing to the overall international revenue.
- API business recovered well, boosting the segment’s revenue.
Acquired Portfolios
Acquired brands continued to contribute positively to overall revenue and growth:
- Sporlac franchise revenue reached INR 153 crores.
- Azmarda clocked sales of INR 79 crores.
- The ophthalmology portfolio from Novartis is progressing well after integration in January 2024, with 10% growth in H1 FY26.
Sustainability Initiatives
JB Pharma remains committed to sustainability, with ongoing efforts to reduce its environmental impact and promote social responsibility:
- >34% decrease in Scope 1 emissions.
- >273% increase in renewable energy consumption.
Source: BSE
